Nearly twelve years after promising results suggested that anti-biofilm agents might be developed into novel therapeutics, there are no such products on the market. In our opinion, the reasons for this have been predominantly economic. Recent developments, however, suggest that there may still be emerging opportunities for the developments of such products.
展开▼